PRESS RELEASE published on 02/07/2024 at 07:30, 2 years ago Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV Evotec SE expands partnership with ABL to develop and manufacture broadly neutralising antibodies against HIV, funded by NIAID. The collaboration aims to supply clinical material for ongoing global trials Evotec SE ABL Broadly Neutralising Antibodies HIV NIAID
PRESS RELEASE published on 01/22/2024 at 07:30, 2 years ago Evotec SE: Invitation to Conference Call Evotec SE is going to hold a conference call to provide a statement and a business update on January 22, 2024, featuring the Chairwoman of Evotec's Supervisory Board and Evotec's CEO. The call will cover the Company's commitment to compliance with Corporate Governance standards and transparent communication, as well as the execution of its existing strategy and recent market developments. For more details, including webcast access and conference call registration, please visit the provided links. Conference Call Business Update Evotec SE Corporate Governance Market Developments
PRESS RELEASE published on 11/08/2023 at 07:00, 2 years 3 months ago Evotec SE reports results for the first nine months 2023 and provides corporate update
PRESS RELEASE published on 11/07/2023 at 07:30, 2 years 3 months ago Evotec and Dewpoint Therapeutics enter strategic partnership in oncology
PRESS RELEASE published on 11/01/2023 at 12:05, 2 years 3 months ago Evotec SE to announce results for the first nine months 2023 on 08 November 2023
PRESS RELEASE published on 10/05/2023 at 07:30, 2 years 4 months ago Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
PRESS RELEASE published on 09/27/2023 at 07:30, 2 years 4 months ago Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy
PRESS RELEASE published on 09/26/2023 at 13:35, 2 years 4 months ago Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases
PRESS RELEASE published on 08/29/2023 at 07:00, 2 years 5 months ago Evotec SE reports results for the first half-year 2023 and provides corporate updates
PRESS RELEASE published on 08/22/2023 at 14:00, 2 years 5 months ago Evotec SE reports first half-year 2023 results on 29 August 2023
Published on 02/10/2026 at 22:15, 35 minutes ago Earthwise Minerals Completes Private Placement and Makes Changes to the Management Team
Published on 02/10/2026 at 15:30, 7 hours 20 minutes ago Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/10/2026 at 15:00, 7 hours 50 minutes ago Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 14:30, 8 hours 20 minutes ago Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/10/2026 at 22:28, 21 minutes ago EQS-Adhoc: Gerresheimer AG reschedules publication of annual and consolidated financial statements for 2025 and initiates sale of Centor Inc.
Published on 02/10/2026 at 19:07, 3 hours 43 minutes ago Wacker Neuson Group publishes preliminary financial year 2025 figures and shows a positive outlook
Published on 02/10/2026 at 19:06, 3 hours 43 minutes ago EQS-Adhoc: Wacker Neuson Group publishes preliminary financial year 2025 figures
Published on 02/10/2026 at 19:05, 3 hours 44 minutes ago Quantifind Can Unlock Up to $177.9M in Annual Compliance Efficiency for Tier 1 Banks According to Celent Report
Published on 02/10/2026 at 18:52, 3 hours 58 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/10/2026 at 18:24, 4 hours 25 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 4 hours 25 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
Published on 02/10/2026 at 18:00, 4 hours 50 minutes ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie
Published on 02/10/2026 at 18:00, 4 hours 50 minutes ago CIS wins several strategic contracts in Africa, South America and Asia